Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

German Ott

Showing results (221-230 of 374) with videos related to

Pageof 38
Sort By:
Histopathology|September 5, 2025
Current practice of pathologic response assessment following chemoimmunotherapy for non-small cell lung cancer (NSCLC) in Germany: first real-world data from the multicentre Re-GraDE studyFelix Elsner, Christiane Kümpers, German Ott, et al.
Scientific Reports|July 21, 2016
Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenesStefan Winter, Pascale Fisel, Florian Büttner, et al.
Virchows Archiv : an International Journal of Pathology|June 26, 2012
Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classificationArne Warth, Judith Cortis, Ludger Fink, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2015
Survival of human lymphoma cells requires B-cell receptor engagement by self-antigensRyan M Young, Tianyi Wu, Roland Schmitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2021
Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphomaMarco Fangazio, Erik Ladewig, Karen Gomez, et al.
Cancers|March 25, 2022
Metabolic Profiling of Thymic Epithelial Tumors Hints to a Strong Warburg Effect, Glutaminolysis and Precarious Redox Homeostasis as Potential Therapeutic TargetsMohammad Alwahsh, Robert Knitsch, Rosemarie Marchan, et al.
British Journal of Haematology|September 22, 2005
Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL NetworkMarkus Tiemann, Carsten Schrader, Wolfram Klapper, et al.
Blood|January 22, 2013
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphomaHeike Horn, Marita Ziepert, Claudia Becher, et al.
Blood Advances|January 30, 2023
Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysisCatherine Thieblemont, Bettina Altmann, Fabian Frontzek, et al.
Blood|September 21, 2007
Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphomaKen H Young, Dennis D Weisenburger, Bhavana J Dave, et al.
Pageof 38

Showing results (221-230 of 374) with videos related to

Sort By:
Pageof 38
Histopathology|September 5, 2025
Current practice of pathologic response assessment following chemoimmunotherapy for non-small cell lung cancer (NSCLC) in Germany: first real-world data from the multicentre Re-GraDE studyFelix Elsner, Christiane Kümpers, German Ott, et al.
Scientific Reports|July 21, 2016
Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenesStefan Winter, Pascale Fisel, Florian Büttner, et al.
Virchows Archiv : an International Journal of Pathology|June 26, 2012
Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classificationArne Warth, Judith Cortis, Ludger Fink, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2015
Survival of human lymphoma cells requires B-cell receptor engagement by self-antigensRyan M Young, Tianyi Wu, Roland Schmitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2021
Genetic mechanisms of HLA-I loss and immune escape in diffuse large B cell lymphomaMarco Fangazio, Erik Ladewig, Karen Gomez, et al.
Cancers|March 25, 2022
Metabolic Profiling of Thymic Epithelial Tumors Hints to a Strong Warburg Effect, Glutaminolysis and Precarious Redox Homeostasis as Potential Therapeutic TargetsMohammad Alwahsh, Robert Knitsch, Rosemarie Marchan, et al.
British Journal of Haematology|September 22, 2005
Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL NetworkMarkus Tiemann, Carsten Schrader, Wolfram Klapper, et al.
Blood|January 22, 2013
MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphomaHeike Horn, Marita Ziepert, Claudia Becher, et al.
Blood Advances|January 30, 2023
Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysisCatherine Thieblemont, Bettina Altmann, Fabian Frontzek, et al.
Blood|September 21, 2007
Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAILreceptor-2, predict for poor survival in diffuse large B-cell lymphomaKen H Young, Dennis D Weisenburger, Bhavana J Dave, et al.
Pageof 38